Imperial Brands has announced an additional £1.45 billion ($1.95 billion) share buyback program, reinforcing investor confidence as the company continues to deliver on its growth strategy. The maker of Winston cigarettes and blu e-cigarettes said it remains on track to meet its annual financial targets, driven by strong pricing and rising demand for next-generation tobacco alternatives.
The company previously forecast low single-digit growth in tobacco and next-generation product revenue at constant currency, along with mid-single-digit growth in adjusted operating profit for the year. This steady performance highlights Imperial’s successful efforts to balance traditional tobacco sales with the rapid expansion of smoke-free and vaping products — key areas for future growth.
Imperial Brands’ stock has rebounded significantly since May, when former CEO Stefan Bomhard announced his retirement. The recovery reflects renewed optimism around the company’s long-term vision and consistent delivery on its transformation strategy. On October 1, Lukas Paravicini officially took over as CEO, signaling a new chapter for the British tobacco group.
The company expects its strong market share gains in the U.S., Germany, and Australia to offset softer performance in Spain and the UK. Analysts view the expanded share buyback as a clear signal of financial stability and management’s confidence in sustainable cash flow generation.
By deepening its focus on reduced-risk products and rewarding shareholders through repurchases, Imperial Brands continues to position itself competitively in a rapidly evolving global tobacco market.


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Apple Turns 50: From Garage Startup to AI Crossroads
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 



